Status:
UNKNOWN
Promote Brain Resilience for the Coronavirus (COVID-19) Pandemic
Lead Sponsor:
Institut Guttmann
Collaborating Sponsors:
University of Barcelona
Conditions:
Transcranial Direct Current Stimulation
Mental Health Issue
Eligibility:
All Genders
40-65 years
Phase:
NA
Brief Summary
Background: By the end of 2020, the coronavirus disease (COVID-19) pandemic resulted in over 84 million cases and nearly 2 million deaths. Continued confinement and restriction are expected to negat...
Detailed Description
As of the end of 2020, the coronavirus (COVID-19) pandemic had resulted in over 88 million confirmed cases and nearly 2 million deaths worldwide. Recurring waves of infection are forcing to impose con...
Eligibility Criteria
Inclusion
- No neurologic and neuropsychiatric diagnosis
Exclusion
- Contraindication to receive safety tACS
Key Trial Info
Start Date :
September 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 15 2023
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT05293431
Start Date
September 1 2022
End Date
November 15 2023
Last Update
June 23 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut Guttmann
Badalona, Barcelona, Spain, 08916